Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies
Primary liver cancer, or hepatocellular carcinoma (HCC), is a major worldwide cause of death from carcinoma. Most patients are not candidates for surgery and medical therapies, including new immunotherapies, have not shown major improvements since the modest benefit seen with the introduction of sor...
Saved in:
Published in | Pharmaceutics Vol. 12; no. 12; p. 1243 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
20.12.2020
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!